Treatment delay and treatment pattern modifications among epithelial ovarian cancer patients during the COVID‐19 pandemic: A retrospective cohort study
Autor: | Nino José Wilson Moterani Júnior, Vinicius Cesar Moterani, Francisco Jose Candido dos Reis |
---|---|
Rok vydání: | 2022 |
Předmět: | |
Zdroj: | Journal of Surgical Oncology. 126:1155-1161 |
ISSN: | 1096-9098 0022-4790 |
DOI: | 10.1002/jso.27048 |
Popis: | The coronavirus disease 2019 (COVID-19) pandemic disrupted healthcare access and medical treatment, including oncological care. Treatment delay in ovarian cancer could impact survival. We aimed to assess if there were delays and treatment changes in a cohort of epithelial ovarian cancer patients.A retrospective cohort of epithelial ovarian cancer patients included cases diagnosed during the first 22 months of the COVID-19 pandemic in the state of Sao Paulo and those diagnosed in the 22 months preceding the outbreak. Time-to-treat was measured in days. In each group, surgery and chemotherapy proportions were assessed according to healthcare insurance status.A 56.2% reduction in epithelial ovarian cancer diagnosis was identified during the pandemic group compared to the prepandemic group; fewer patients were diagnosed in stage I (p 0.01). Time-to-treat increased from 18.9 to 23 days (p 0.01). Surgery in the public sector fell from 74.6% to 65.3% during the pandemic, compared to 87.1% to 68.8% in the private sector.There were fewer overall diagnoses, reduced stage I diagnosis, increased time-to-treat, and a reduction in the proportion of patients submitted to surgery. Brazil's public healthcare system demonstrated a higher resiliency to treatment change than the private sector. |
Databáze: | OpenAIRE |
Externí odkaz: |